InvestSMART

EMvision Medical Devices Limited (ASX: EMV) - Announcements

Current share price for EMV : $1.710 0.04 (2.40%)+

ASX company news and announcements for EMvision Medical Devices Limited (EMV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All EMvision Medical Devices Limited (EMV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than EMvision Medical Devices Limited (EMV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for EMvision Medical Devices Limited (EMV)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$159 AGM Address & Presentation 26 Nov 2019 10:38AM $0.720 $1.710 risen by 137.50%
$159 Appendix 3B & Cleansing Notice 13 Nov 2019 6:51PM $0.800 $1.710 risen by 113.75%
$159 EMVision Completes $4.5M Placement 5 Nov 2019 9:45AM $0.850 $1.710 risen by 101.18%
$159 Trading Halt 1 Nov 2019 9:23AM $0.850 $1.710 risen by 101.18%
$159 Appendix 4C - quarterly 31 Oct 2019 9:32AM $0.850 $1.710 risen by 101.18%
$159 EMVision Completes First Clinical Unit Targeting Stroke 31 Oct 2019 9:28AM $0.850 $1.710 risen by 101.18%
$159 Notice of Annual General Meeting/Proxy Form 25 Oct 2019 10:18AM $0.895 $1.710 risen by 91.06%
$159 Response to ASX Price Query 9 Oct 2019 5:17PM $0.800 $1.710 risen by 113.75%
$159 Trading Halt Request 9 Oct 2019 4:17PM $0.800 $1.710 risen by 113.75%
$159 Trading Halt 9 Oct 2019 3:55PM $0.800 $1.710 risen by 113.75%
$159 Pause In Trading 9 Oct 2019 3:33PM $0.800 $1.710 risen by 113.75%
$159 On Target For Trial To Commence Q4 Calendar 2019 3 Sep 2019 8:28AM $0.370 $1.710 risen by 362.16%
$159 Appendix 4G & Corporate Governance Statement 30 Aug 2019 3:50PM $0.370 $1.710 risen by 362.16%
$159 Appendix 4E & Annual Report 30 June 2019 30 Aug 2019 3:49PM $0.370 $1.710 risen by 362.16%
$159 Bioshares Biotech Summit Presentation 25 Jul 2019 12:07PM $0.385 $1.710 risen by 344.16%
$159 Investor Presentation 25 Jul 2019 12:06PM $0.385 $1.710 risen by 344.16%
$159 Appendix 4C - quarterly 23 Jul 2019 10:41AM $0.370 $1.710 risen by 362.16%
$159 Release of Restricted Securities from Escrow 8 Jul 2019 8:19AM $0.420 $1.710 risen by 307.14%
$159 Appendix 3B 5 Jul 2019 4:56PM $0.420 $1.710 risen by 307.14%
$159 EMvision Appoints Head of Quality & Regulatory Affairs 3 Jul 2019 8:23AM $0.380 $1.710 risen by 350%
$159 Brain Scanner Development Update 1 Jul 2019 8:24AM $0.365 $1.710 risen by 368.49%
$159 EMvision Appoints Clinical Advisory Board 12 Jun 2019 9:59AM $0.380 $1.710 risen by 350%
$159 Change of Director's Interest Notice 5 Jun 2019 9:57AM $0.375 $1.710 risen by 356%
$159 Australian Stoke Alliance Successful in Frontiers Bid 22 May 2019 10:34AM $0.400 $1.710 risen by 327.50%
$159 Appendix 3B Release of Restricted Securities 30 Apr 2019 8:17AM $0.430 $1.710 risen by 297.67%

326 - 350 of 376 results

Page 14 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.